PT67365B - Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques - Google Patents

Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques

Info

Publication number
PT67365B
PT67365B PT67365A PT6736577A PT67365B PT 67365 B PT67365 B PT 67365B PT 67365 A PT67365 A PT 67365A PT 6736577 A PT6736577 A PT 6736577A PT 67365 B PT67365 B PT 67365B
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical composition
composition containing
organic compounds
new organic
Prior art date
Application number
PT67365A
Other languages
English (en)
Portuguese (pt)
Other versions
PT67365A (fr
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT67365A publication Critical patent/PT67365A/fr
Publication of PT67365B publication Critical patent/PT67365B/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PT67365A 1976-12-07 1977-12-05 Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques PT67365B (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1535376 1976-12-07
CH8277 1977-01-05

Publications (2)

Publication Number Publication Date
PT67365A PT67365A (fr) 1978-01-01
PT67365B true PT67365B (fr) 1979-09-20

Family

ID=25683446

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67365A PT67365B (fr) 1976-12-07 1977-12-05 Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques

Country Status (17)

Country Link
JP (1) JPS5384955A (fr)
AT (1) AT366361B (fr)
CA (1) CA1105475A (fr)
DE (1) DE2752659A1 (fr)
DK (1) DK527877A (fr)
ES (1) ES464747A1 (fr)
FI (1) FI773595A (fr)
FR (1) FR2373513A1 (fr)
GB (1) GB1597140A (fr)
IE (1) IE45929B1 (fr)
IL (1) IL53533A (fr)
NL (1) NL7713364A (fr)
NZ (1) NZ185884A (fr)
PH (1) PH13932A (fr)
PT (1) PT67365B (fr)
SE (1) SE7713471L (fr)
SU (1) SU927110A3 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS639500B2 (fr) * 1978-07-14 1988-02-29 Amerikan Hosupitaru Sapurai Corp
US4314082A (en) * 1978-07-14 1982-02-02 American Hospital Supply Corporation Derivatives of 2-amino-6,7-dihydroxytetrahydro naphthalene (ADTN)
EP0026848B1 (fr) 1979-09-14 1983-05-04 Sandoz Ag Dérivés de tétraline, leur préparation et médicaments contenant ces composés
EP0033789B1 (fr) * 1980-01-30 1984-03-07 American Hospital Supply Corporation 2-alpha-Methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalène, ses sels, et procédé pour sa préparation
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
WO1982004042A1 (fr) * 1981-05-11 1982-11-25 Folke Lars Erik Arvidsson Derives iii de tetraline utiles therapeutiquement, procedes de preparation et preparations pharmaceutiques contenant ces composes
US4402974A (en) 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
US4500545A (en) * 1982-11-16 1985-02-19 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4448990A (en) * 1982-11-16 1984-05-15 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US5177112A (en) * 1983-01-03 1993-01-05 Whitby Research, Inc. Substituted 2-aminotetralins
US4722933A (en) * 1985-12-20 1988-02-02 Nelson Research & Development Co. Substituted 2-aminotetralins
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
GB2157950B (en) * 1984-05-04 1988-11-02 Nelson Res & Dev Selective d-2 dopamine receptor agonist
CA1331191C (fr) 1988-03-25 1994-08-02 Bengt Ronny Andersson Derives de la tetraline utiles comme medicaments
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
US5380748A (en) * 1991-03-07 1995-01-10 Zeria Pharmaceutical Co., Ltd. Trialkylamine derivative and ameliorant for digestive tract movement containing the same
SI0923542T1 (en) * 1996-05-31 2004-02-29 Pharmacia & Upjohn Company Aryl substituted cyclic amines as selective dopamine d3 ligands
IT1294931B1 (it) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
AR054363A1 (es) * 2005-05-23 2007-06-20 Astrazeneca Ab Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
EP2723727B1 (fr) * 2011-06-27 2017-03-01 Shan Dong Luye Pharmaceutical Co., Ltd. Procédé pour la préparation industrielle d'amino-5,6,7,8-tétrahydronaphtol substitué sur l'azote

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1017359A (en) * 1972-07-03 1977-09-13 Frederic P. Hauck Substituted cyclic polymethylene phenols

Also Published As

Publication number Publication date
FI773595A (fi) 1978-06-08
NZ185884A (en) 1980-04-28
ES464747A1 (es) 1979-01-01
IL53533A (en) 1982-07-30
PH13932A (en) 1980-11-04
GB1597140A (en) 1981-09-03
FR2373513A1 (fr) 1978-07-07
NL7713364A (nl) 1978-06-09
JPS5384955A (en) 1978-07-26
DE2752659A1 (de) 1978-06-08
AT366361B (de) 1982-04-13
ATA871977A (de) 1981-08-15
DK527877A (da) 1978-06-08
CA1105475A (fr) 1981-07-21
PT67365A (fr) 1978-01-01
FR2373513B1 (fr) 1980-08-22
IL53533A0 (en) 1978-03-10
SE7713471L (sv) 1978-06-08
SU927110A3 (ru) 1982-05-07
IE45929B1 (en) 1982-12-29
IE45929L (en) 1978-06-07
JPS6214540B2 (fr) 1987-04-02

Similar Documents

Publication Publication Date Title
PT67365A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT68448A (fr) Procede pour la preparation d'une composition pharmaceutique contenant nouveaux composes organiques
PT69072A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT66120A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT68306A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouvaux composes organiques
PT66186B (fr) Procede pour la preparation d'une composition pharmaceutique avec nouveaux composes organiques
PT70129A (fr) Procede pour la preparation d'une composition pharmaceutique contenant de nouveaux composes organiques
PT66850B (fr) Procede pour la preparation d'une composition pharmaceutique
PT65264A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des composes organiques
PT67522A (fr) Procede pour la preparation d'une composition pharmaceutique avec de nouveaux composes organiques
PT67562B (fr) Procede pour la preparation d'une composition pharmaceutique contenant de nouveaux composes organiques
PT68062B (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT68216A (fr) Procede pour la preparation d'une composition pharmaceu- tique contenant des nouveaux composes organiques
PT66166B (fr) Procede pour la preparation d'une composition pharmaceutique contenant nouveaux composes organiques
PT64839A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT68345A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT67407B (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT66758B (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT67623A (pt) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT68218A (fr) Procede pour la preparation d'une composition pharmaceu- tique contenant des nouveaux composes organiques
PT66551B (fr) Procede pour la preparation d'une composition pharmaceutique avec des nouveaux composes organiques
PT67052A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques
PT69168A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouvaux composes organiques
PT67791A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des composes organiques
PT69318A (fr) Procede pour la preparation d'une composition pharmaceutique contenant des nouveaux composes organiques